Skip Navigation

Johns Hopkins Post-COVID-19 Care

a home care nurse in PPE outside of a patient's home

The Johns Hopkins Post-Acute COVID-19 Team (JH PACT) Program is a collaboration between the Division of Pulmonary & Critical Care Medicine and the Department of Physical Medicine and Rehabilitation. Our goal is to provide interdisciplinary, standardized care to address the unique needs of COVID-19 survivors.

JH PACT consists of two core service lines that work in tandem to provide comprehensive care. As needed, our physicians may refer patients to other specialists to support recovery.
  • Physician Services

    Our pulmonary and rehabilitation physicians conduct appointments via telemedicine or on campus.

  • Therapy Services

    Our rehabilitation therapy services include physical, occupational, speech-language therapy and neuropsychology.

Resources for COVID-19 Survivors

Provider referrals are required for JH PACT clinic appointments. Learn more about referral criteria.

Additional resources:

JH PACT Research Studies

  • Summary: The goal of the COVID Patient Registry is to collect data on individuals who were diagnosed with COVID-19 and who are seen for follow up care at Johns Hopkins. We hope to understand the natural history of the illness and ultimately improve the care and survival of those who were treated for COVID-19 to improve understanding, treatment and survival.

    P.I.: Ann Parker, M.D., Ph.D. Contact:

  • Summary: People with solid organ transplants are at high risk of developing COVID-19, but the long-term neurocognitive aspects of COVID-19 infection (such as anosmia, loss of taste, loss of hearing, headaches, mental “fogginess,” confusion and fatigue) in this population is still not fully understood.

    This study aims to: 1) Estimate the prevalence of mental, cognitive and physical impairments in solid organ transplant patients hospitalized with COVID-19 in the short-term and long-term period; and 2) understand changes in mental, cognitive and physical impairment in solid organ transplant patients hospitalized with COVID-19 in the long-term.

    P.I.: Sami Alasfar, M.B.B.S., M.D. Contact:

  • Summary: Recent data suggests that survivors of COVID-19 report adverse health status, including neurological and cognitive deficits and impaired pulmonary function, even months after discharge. Adult COVID-19 survivors after ICU stay are at higher risk of long-term disabilities and impaired quality of life. Post-hospitalization assessments are important to identify persistent deficits and stagnation in recover, since this may be amenable for early intervention and targeted rehabilitation.

    This study aims to describe the health-related quality of life and the dynamics of neurologic and pulmonary dysfunction and recovery following intensive care admission for COVID-19. The study team will complete a baseline assessment of participants’ health prior to ICU admission, and then participants will complete a series of additional assessments (surveys, brain MRI, PFTs, chest x-ray, etc.) at three time points post-discharge.

    P.I.: Sung-Min Cho, D.O., M.H.S. Contact:

  • Summary: No studies of post-acute COVID-19 symptoms and sequelae have focused specifically on people living with HIV (PWH). Given elevated baseline levels of inflammation and T-cell activation in this population, we hypothesize that PWH are more likely to experience persistent symptoms after acute COVID-19 than HIV negative people.

    This is part of a national study conducted remotely with telephone and online surveys and blood samples collected via a mobile phlebotomy company at the participant’s home. Specifically, this study aims to: 1) formally and prospectively characterize symptoms and sequelae of post-acute COVID-19 in PWH as compared to HIV-negative COVID-19 survivors and PWH and HIV-negative people with no history of COVID-19; and 2) identify blood-based biomarkers or immune signature(s) that associate with prolonged or persistent post-acute COVID-19 symptoms in PWH in comparison with the general population.

    P.I.: Annie Antar, M.D., Ph.D. Contact:


JH PACT in the News

back to top button